Clinical trial
Zyprexa and Task Engagement in Schizophrenia
NCT00440843 · VA Connecticut Healthcare System, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00440843 |
|---|---|
| Title | Zyprexa and Task Engagement in Schizophrenia |
| Official title | Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia |
| Lead sponsor | VA Connecticut Healthcare System, U.S. Fed |
| Collaborators | Clinical Trials Network of Columbia U, Cornell U, and NY Presbyterian Hospital Eli Lilly and Company Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Olanzapine (Zyprexa), Typicals |
| Enrollment | 0 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Feb 27, 2007 |
| Last update posted | Dec 23, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: